Skip to main content
. 2021 Nov 30;13(12):4330. doi: 10.3390/nu13124330

Figure 1.

Figure 1

Prevalence of subjects who had a reduction in VAS value (a) and serum BALP concentration (b) after 6 weeks of treatment. A total of 18 participants were enrolled (control group n = 11, HS pasta n = 7, respectively). Abbreviation: VAS = visual analog scale; BALP = bone-specific alkaline phosphatase.